![](https://investorshub.advfn.com/uicon/486527.png?cb=1571677899)
Friday, September 08, 2023 12:55:54 PM
Backgrounder:
Red_Right_Hand
Re: None
Saturday, December 03, 2022 12:44:14 PM
Post# of 629292
Agnostic?
“A polyclonal but antigen agnostic approach includes the use of autologous whole cell tumour vaccines or tumour lysates, which provide the entire repertoire of a patients’ tumour antigens including mutated neoepitopes without the need for identification of individual antigens." (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282323/)
“T-cell therapies can be antigen agnostic (administered without precise knowledge of the antigens targeted), such as in unmanipulated donor lymphocyte infusions (DLI) and TIL infusion, or targeted to known antigens.” https://www.frontiersin.org/articles/10.3389/fimmu.2020.00276/full
“… many prefer the concept of antigen-agnostic immunotherapies that allow each patient’s immune system to determine its own antigen specificities.” https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(19)30015-4
[
maverick_1
Re: CrashOverride post# 586505
Tuesday, April 18, 2023 3:38:37 PM
Post# of 629291
Poly-ICLC ( ONCOVIR) is located in same area as NWBO!
A month ago found out the following:
Privately held: NO disclosed backers for their trialS: $$$
maverick_1 (@maveric92283613) tweeted at 7:39 PM on Tue, Mar 14, 2023:
MAYBE CEO Linda Powers VC minded might consider at some point venturing w/them(in same area!) even though she has already so MANY IRONS in the FIRE it would be a KNOCK em DEAD.
Bearded Vet (@TheeBeardedG) tweeted at 5:15 PM on Tue, Mar 14, 2023:
It appears to be an absolute powerhouse piece of the puzzle .
Its in a dozen combo trials and is possibly a lung cancer cure piece.
Also called Hiltonol. Its in hiv drug combos too.
Also in two known trials with nwbo.
maverick_1 (@maveric92283613) tweeted at 7:59 PM on Tue, Mar 14, 2023:
As it is private it is better suited for Big Rx for lots of reasons IMHO but forward to Dr Rago for his views.
REALISTICALLY & iwasadiver (Dr. Greg Zivic )agrees as well
Going to take either:
HUEMONGUS $ upwards of a few $10’s of BILLIONS IMHO
OR
Meeting of the minds(not easy!) of BOTH for a KNOCK EM ALL DOWN.
I am sure The SUPREME NAVIGATOR has it in her hip pocket!
DIFFERENT STROKES for DIFFERENT FOLKS
Bullish
BULLISH
NWBO
Northwest Biotherapeutics Inc (QB)
0.6949
0.0074 (1.08%)
Volume: 1,563,178
Day Range: 0.683 - 0.7121
Bid: 0.69
Ask: 0.6949
Recent NWBO News
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Read ATLnsider iHub commentaries on Poly-ICLC:
ATLnsider
Re: newman2021 post# 586478
Tuesday, April 18, 2023 1:33:16 PM
Post# of 629305
newman2021, I believe (like Doc logic) that poly-ICLC gives NWBio a lot of negotiating leverage with Merck, Bristol Myers Squibb, and other BPs who have PD-1 and PDL-1 inhibitors. [
Because of the exceptional / miraculous overall survival results, when DCVax is combined with poly-ICLC, big pharma (PD-1 & PDL-1 producers) needs DCVax more than DCVax needs big pharma.
This should help Linda Powers negotiate very favorable partnership agreements with multiple BP partners.
Bullish
BULLISH
AND that of LAGGING Supreme SNIPPER Obstinacy thru out this EPIC exemplify in MANY 9 yr exchanges: 20+ :
https://investorshub.advfn.com/boards/profilea.aspx?user=504388
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171930084
——————————————————
TODAY’s ONCOVIR for LATEST:
Just review EVERY link from this especially from
https://www.oncovir.com/
Then supplement:
https://duckduckgo.com/?q=oncovir&ia=web
NWBO for GENERATIONAL WEALTH only for True LONG HAULERS
that Stuck with these DISRUPTORS and have The LAST LAUGHvs traders, NEOPHTHES
Former TECH Disrptrs $TSLA $AAPL $NVDA $MSFT $GOOG
Former MedDev Disrptrs: $MDT $ABT $ZBH $BSX
DIFFERENT STROKES for DIFFERENT FOLKS
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM